Intech Investment Management LLC Boosts Holdings in Integer Holdings Co. (NYSE:ITGR)

Intech Investment Management LLC increased its holdings in Integer Holdings Co. (NYSE:ITGR) by 51.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,767 shares of the medical equipment provider’s stock after purchasing an additional 3,980 shares during the period. Intech Investment Management LLC’s holdings in Integer were worth $1,559,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in the business. Geode Capital Management LLC lifted its holdings in Integer by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 764,528 shares of the medical equipment provider’s stock worth $99,408,000 after purchasing an additional 9,421 shares in the last quarter. Loomis Sayles & Co. L P raised its holdings in shares of Integer by 3.0% during the 3rd quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider’s stock worth $69,943,000 after acquiring an additional 15,446 shares in the last quarter. Congress Asset Management Co. raised its holdings in shares of Integer by 2.0% during the 4th quarter. Congress Asset Management Co. now owns 498,350 shares of the medical equipment provider’s stock worth $66,041,000 after acquiring an additional 9,565 shares in the last quarter. Charles Schwab Investment Management Inc. raised its holdings in shares of Integer by 1.1% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 408,588 shares of the medical equipment provider’s stock worth $54,146,000 after acquiring an additional 4,559 shares in the last quarter. Finally, Lord Abbett & CO. LLC raised its holdings in shares of Integer by 3.5% during the 3rd quarter. Lord Abbett & CO. LLC now owns 290,120 shares of the medical equipment provider’s stock worth $37,716,000 after acquiring an additional 9,754 shares in the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts have recently issued reports on ITGR shares. Benchmark upped their price objective on Integer from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Friday, February 21st. Wells Fargo & Company reaffirmed an “overweight” rating and set a $160.00 price objective on shares of Integer in a report on Tuesday, December 3rd. Citigroup upped their price objective on Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a report on Wednesday, December 11th. KeyCorp boosted their target price on Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Finally, Oppenheimer downgraded Integer from an “outperform” rating to a “market perform” rating in a research report on Friday, February 21st. Two analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $149.00.

Integer Stock Performance

Shares of Integer stock opened at $115.07 on Friday. The stock’s fifty day moving average is $132.59 and its two-hundred day moving average is $132.31. The company has a market capitalization of $3.87 billion, a PE ratio of 34.25, a price-to-earnings-growth ratio of 1.72 and a beta of 1.24. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62. Integer Holdings Co. has a 52 week low of $107.11 and a 52 week high of $146.36.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 EPS for the quarter, missing the consensus estimate of $1.46 by ($0.03). The business had revenue of $449.50 million during the quarter, compared to the consensus estimate of $446.28 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. As a group, analysts expect that Integer Holdings Co. will post 6.01 earnings per share for the current year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.